Sage Therapeutics, Inc. Operating Lease, Liability, Noncurrent
Sage Therapeutics, Inc. had Operating Lease, Liability, Noncurrent of $9.54 million as of 2025-06-30, per its 10-Q filed 2025-07-30.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2025-07-30
- 2025-06-30: Operating Lease, Liability, Noncurrent $9.54M.
- 2025-03-31: Operating Lease, Liability, Noncurrent $10.04M.
- 2024-12-31: Operating Lease, Liability, Noncurrent $10.52M.
- 2024-09-30: Operating Lease, Liability, Noncurrent $10.19M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2025-06-30 | $9.54M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $10.04M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $10.52M 10-Q · filed 2025-07-30 |
| 2024-09-30 | $10.19M 10-Q · filed 2024-10-29 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-11 |
| 2023-06-30 | $1.00M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $2.76M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $4.49M 10-K · filed 2024-02-14 |
| 2022-09-30 | $6.16M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $7.80M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $9.40M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $10.96M 10-K · filed 2023-02-16 |
| 2021-09-30 | $12.48M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $13.96M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $15.41M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $19.44M 10-K · filed 2022-02-24 |
| 2020-09-30 | $21.07M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $22.66M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $24.95M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $26.85M 10-K · filed 2021-02-24 |
| 2019-09-30 | $31.36M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $33.31M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $34.53M 10-Q · filed 2019-05-02 |